Holocene Advisors LP Reduces Stock Position in McKesson Corporation $MCK

Holocene Advisors LP decreased its position in McKesson Corporation (NYSE:MCK) by 83.2% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 63,820 shares of the company’s stock after selling 316,205 shares during the quarter. Holocene Advisors LP owned approximately 0.05% of McKesson worth $49,304,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently modified their holdings of MCK. GGM Financials LLC purchased a new stake in shares of McKesson during the third quarter worth about $25,000. State of Wyoming purchased a new position in McKesson during the 2nd quarter valued at about $29,000. Hopwood Financial Services Inc. purchased a new position in McKesson during the 3rd quarter valued at about $31,000. Abound Wealth Management raised its position in McKesson by 104.3% during the 3rd quarter. Abound Wealth Management now owns 47 shares of the company’s stock valued at $37,000 after purchasing an additional 24 shares during the last quarter. Finally, Delos Wealth Advisors LLC purchased a new stake in McKesson in the 2nd quarter worth approximately $35,000. 85.07% of the stock is owned by institutional investors.

Insider Buying and Selling at McKesson

In other news, Director Maria Martinez sold 349 shares of the company’s stock in a transaction dated Thursday, February 19th. The shares were sold at an average price of $939.87, for a total value of $328,014.63. Following the sale, the director directly owned 301 shares of the company’s stock, valued at $282,900.87. This represents a 53.69% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Leann B. Smith sold 190 shares of McKesson stock in a transaction dated Tuesday, February 17th. The shares were sold at an average price of $945.00, for a total transaction of $179,550.00. Following the transaction, the executive vice president directly owned 2,989 shares of the company’s stock, valued at approximately $2,824,605. This trade represents a 5.98% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 3,868 shares of company stock valued at $3,743,820. Company insiders own 0.08% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on MCK. Robert W. Baird set a $968.00 price objective on McKesson in a research report on Wednesday, January 14th. Leerink Partners restated an “outperform” rating and set a $1,085.00 target price on shares of McKesson in a report on Thursday, March 5th. Zacks Research lowered McKesson from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, November 25th. Raymond James Financial set a $970.00 price target on shares of McKesson in a report on Thursday, March 5th. Finally, Mizuho upped their price objective on shares of McKesson from $880.00 to $885.00 and gave the stock a “neutral” rating in a report on Thursday, February 5th. Thirteen equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $960.93.

McKesson Stock Performance

McKesson stock opened at $943.43 on Tuesday. McKesson Corporation has a fifty-two week low of $637.00 and a fifty-two week high of $999.00. The stock’s 50 day simple moving average is $896.29 and its two-hundred day simple moving average is $828.19. The stock has a market cap of $115.56 billion, a price-to-earnings ratio of 27.13, a PEG ratio of 1.51 and a beta of 0.38.

McKesson (NYSE:MCK) last announced its earnings results on Wednesday, February 4th. The company reported $9.34 earnings per share (EPS) for the quarter, topping the consensus estimate of $9.19 by $0.15. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.The firm had revenue of $106.16 billion during the quarter, compared to analyst estimates of $105.98 billion. During the same quarter in the prior year, the company earned $8.03 EPS. The business’s revenue was up 11.4% compared to the same quarter last year. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. On average, analysts predict that McKesson Corporation will post 32.77 earnings per share for the current year.

McKesson Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 1st. Shareholders of record on Monday, March 2nd will be issued a $0.82 dividend. The ex-dividend date is Monday, March 2nd. This represents a $3.28 dividend on an annualized basis and a yield of 0.3%. McKesson’s dividend payout ratio is 9.43%.

About McKesson

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.